305 related articles for article (PubMed ID: 8497270)
1. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.
Nolan GP; Fujita T; Bhatia K; Huppi C; Liou HC; Scott ML; Baltimore D
Mol Cell Biol; 1993 Jun; 13(6):3557-66. PubMed ID: 8497270
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family.
Pan J; McEver RP
J Biol Chem; 1995 Sep; 270(39):23077-83. PubMed ID: 7559449
[TBL] [Abstract][Full Text] [Related]
3. The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.
Naumann M; Wulczyn FG; Scheidereit C
EMBO J; 1993 Jan; 12(1):213-22. PubMed ID: 8428580
[TBL] [Abstract][Full Text] [Related]
4. Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.
Tewari M; Dobrzanski P; Mohn KL; Cressman DE; Hsu JC; Bravo R; Taub R
Mol Cell Biol; 1992 Jun; 12(6):2898-908. PubMed ID: 1588976
[TBL] [Abstract][Full Text] [Related]
5. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
6. BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins.
Zhang Q; Didonato JA; Karin M; McKeithan TW
Mol Cell Biol; 1994 Jun; 14(6):3915-26. PubMed ID: 8196632
[TBL] [Abstract][Full Text] [Related]
7. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation.
Kunsch C; Ruben SM; Rosen CA
Mol Cell Biol; 1992 Oct; 12(10):4412-21. PubMed ID: 1406630
[TBL] [Abstract][Full Text] [Related]
8. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
Beg AA; Ruben SM; Scheinman RI; Haskill S; Rosen CA; Baldwin AS
Genes Dev; 1992 Oct; 6(10):1899-913. PubMed ID: 1340770
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells.
Cordle SR; Donald R; Read MA; Hawiger J
J Biol Chem; 1993 Jun; 268(16):11803-10. PubMed ID: 8505309
[TBL] [Abstract][Full Text] [Related]
10. The proto-oncogene bcl-3 encodes an I kappa B protein.
Kerr LD; Duckett CS; Wamsley P; Zhang Q; Chiao P; Nabel G; McKeithan TW; Baeuerle PA; Verma IM
Genes Dev; 1992 Dec; 6(12A):2352-63. PubMed ID: 1459457
[TBL] [Abstract][Full Text] [Related]
11. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
12. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
Wulczyn FG; Naumann M; Scheidereit C
Nature; 1992 Aug; 358(6387):597-9. PubMed ID: 1501714
[TBL] [Abstract][Full Text] [Related]
13. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
[TBL] [Abstract][Full Text] [Related]
14. Purification, reconstitution, and I kappa B association of the c-Rel-p65 (RelA) complex, a strong activator of transcription.
Hansen SK; Baeuerle PA; Blasi F
Mol Cell Biol; 1994 Apr; 14(4):2593-603. PubMed ID: 8139561
[TBL] [Abstract][Full Text] [Related]
15. Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).
Duckett CS; Perkins ND; Kowalik TF; Schmid RM; Huang ES; Baldwin AS; Nabel GJ
Mol Cell Biol; 1993 Mar; 13(3):1315-22. PubMed ID: 8441377
[TBL] [Abstract][Full Text] [Related]
16. Members of the nuclear factor kappa B family transactivate the murine c-myb gene.
Toth CR; Hostutler RF; Baldwin AS; Bender TP
J Biol Chem; 1995 Mar; 270(13):7661-71. PubMed ID: 7706314
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site.
Oeth PA; Parry GC; Kunsch C; Nantermet P; Rosen CA; Mackman N
Mol Cell Biol; 1994 Jun; 14(6):3772-81. PubMed ID: 8196620
[TBL] [Abstract][Full Text] [Related]
18. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
[TBL] [Abstract][Full Text] [Related]
19. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits.
Brown AM; Linhoff MW; Stein B; Wright KL; Baldwin AS; Basta PV; Ting JP
Mol Cell Biol; 1994 May; 14(5):2926-35. PubMed ID: 8164652
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
Scheinman RI; Beg AA; Baldwin AS
Mol Cell Biol; 1993 Oct; 13(10):6089-101. PubMed ID: 8413211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
